biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by frohlir944on Jun 27, 2017 3:32pm

142 Views

Post# 26410375

RE:Mark Day's selection as CEO got me looking, London sealed it

Welcome to the party,

I hope that you go into this as an oxidized filine and come out as a golden Lion.

I believe that this may be one of those opertunities that truly doesnt come along very often and will make quite a few people a big bag of money.

The important people that have seen more of the information than we have are betting their reputations and careers on it.

I only hope that you don't get any oppertunities to add on weakness anywhere near these levels and that the next weakness will be at a considerably higher level than we are seeing now!

Best of luck to all of us!

Bullboard Posts

The top 10 Canadian medical stocks